BioNexus Gene Lab Corp — Investor Relations & Filings
Filings indexed
139
across all filing types
Latest filing
2026-05-15
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
BGLC
BioNexus Gene Lab Corp. is a biotechnology company that specializes in precision diagnostics and gene-based technologies. The company focuses on the development and commercialization of advanced molecular diagnostics and genetic testing. Its core service involves non-invasive, blood-based dynamic genome screening for the early detection of an individual's susceptibility to certain diseases. Utilizing RNA research and screening facilities, BioNexus aims to identify health risks at their earliest stages to enable proactive health management.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 10-Q | 2026-05-15 | English | |
| 10-K - BioNexus Gene Lab Corp (0001737523) (Filer) | 2026-04-14 | English | |
| 8-K - BioNexus Gene Lab Corp (0001737523) (Filer) | 2026-03-17 | English | |
| 8-K - BioNexus Gene Lab Corp (0001737523) (Filer) | 2026-02-23 | English | |
| 8-K Filing | 2026-02-03 | English | |
| FORM 8-K | 2025-12-30 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
5 filings
| |||||
| 46363257 | FORM 10-Q | 2026-05-15 | English | ||
| 34528034 | 10-K - BioNexus Gene Lab Corp (0001737523) (Filer) | 2026-04-14 | English | ||
| 32966568 | 8-K - BioNexus Gene Lab Corp (0001737523) (Filer) | 2026-03-17 | English | ||
| 32827482 | 8-K - BioNexus Gene Lab Corp (0001737523) (Filer) | 2026-02-23 | English | ||
| 31531100 | 8-K Filing | 2026-02-03 | English | ||
|
2025
10 filings
| |||||
| 13103873 | FORM 8-K | 2025-12-30 | English | ||
| 13103874 | FORM 8-K | 2025-12-23 | English | ||
| 13103875 | DEF 14A | 2025-12-03 | English | ||
| 13103878 | FORM 8-K | 2025-12-02 | English | ||
| 13103881 | FORM 10-Q | 2025-11-14 | English | ||
| 13103883 | PRE 14A | 2025-11-14 | English | ||
| 13103882 | FORM 8-K | 2025-11-13 | English | ||
| 13103885 | FORM 8-K | 2025-11-12 | English | ||
| 13103884 | FORM S-3 | 2025-11-07 | English | ||
| 13103887 | FORM 8-K | 2025-10-23 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
A contract research organization supporting drug discovery …
|
CRL | US | Professional, scientific and te… |
|
ChemPartner PharmaTech Co., Ltd.
Global CRO and CDMO providing integrated drug discovery and…
|
300149 | CN | Professional, scientific and te… |
|
CHIMERIC THERAPEUTICS LIMITED
Clinical-stage cell therapy company developing CAR T and NK…
|
CHM | AU | Professional, scientific and te… |
|
China National Electric Apparatus Research Institute Co., Ltd.
R&D institution for electrical and electronics testing, equ…
|
688128 | CN | Professional, scientific and te… |
|
Chiome Bioscience Inc.
Clinical-stage biotech company developing antibody-based th…
|
4583 | JP | Professional, scientific and te… |
|
CHITOGENX INC
Clinical stage regenerative medicine company focused on nov…
|
CHGX | CA | Professional, scientific and te… |
|
Chordate Medical Holding AB
Develops a patented, drug-free neuromodulation treatment fo…
|
CMH | SE | Professional, scientific and te… |
|
Chordia Therapeutics,Inc
Clinical-stage biotech developing novel cancer therapies ta…
|
190A | JP | Professional, scientific and te… |
|
Cibus, Inc.
Develops and licenses plant traits using non-GMO precision …
|
CBUS | US | Professional, scientific and te… |
|
Circio Holding ASA
Clinical-stage company developing circular RNA medicines an…
|
CRNA | NO | Professional, scientific and te… |
BioNexus Gene Lab Corp via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35220/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35220 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35220 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35220 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35220}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BioNexus Gene Lab Corp (id: 35220)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.